|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 |
| (11) | Number of the document | 2321651 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09800069.8 |
| Date of filing the European patent application | 2009-07-23 | |
| (97) | Date of publication of the European application | 2011-05-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/059505 |
| Date | 2009-07-23 |
| (87) | Number | WO 2010/010153 |
| Date | 2010-01-28 |
| (30) | Number | Date | Country code |
| 08161014 | 2008-07-23 | EP |
| (72) |
HESS, Georg, DE
HORSCH, Andrea, DE
ZDUNEK, Dietmar, DE
|
| (73) |
Roche Diagnostics GmbH,
Sandhofer Strasse 116, 68305 Mannheim,
DE
F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, CH |
| (54) | IDENTIFICATION OF SUBJECTS BEING SUSCEPTIBLE TO ANTI-ANGIOGENESIS THERAPY |
| IDENTIFICATION OF SUBJECTS BEING SUSCEPTIBLE TO ANTI-ANGIOGENESIS THERAPY |